Neil Vargesson

4.1k total citations · 1 hit paper
68 papers, 2.9k citations indexed

About

Neil Vargesson is a scholar working on Molecular Biology, Hematology and Cell Biology. According to data from OpenAlex, Neil Vargesson has authored 68 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 18 papers in Hematology and 18 papers in Cell Biology. Recurrent topics in Neil Vargesson's work include Multiple Myeloma Research and Treatments (18 papers), Developmental Biology and Gene Regulation (17 papers) and Protein Degradation and Inhibitors (16 papers). Neil Vargesson is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Developmental Biology and Gene Regulation (17 papers) and Protein Degradation and Inhibitors (16 papers). Neil Vargesson collaborates with scholars based in United Kingdom, United States and Germany. Neil Vargesson's co-authors include Lynda Erskine, Cheryll Tickle, Jonathan D. W. Clarke, William D. Figg, Ed Laufer, Julian Lewis, Erin R. Gardner, Cécile Crosnier, Linda Ariza‐McNaughton and Alastair Morrison and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and PLoS ONE.

In The Last Decade

Neil Vargesson

66 papers receiving 2.9k citations

Hit Papers

Thalidomide‐induced teratogenesis: History and mechanisms 2015 2026 2018 2022 2015 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Vargesson United Kingdom 26 1.9k 430 408 368 207 68 2.9k
Kevin P. Williams United States 32 3.1k 1.6× 599 1.4× 454 1.1× 177 0.5× 204 1.0× 78 3.9k
Larry L. Deaven United States 33 3.3k 1.7× 1.1k 2.5× 347 0.9× 386 1.0× 177 0.9× 70 5.0k
Michael B. Gorin United States 40 3.0k 1.6× 781 1.8× 415 1.0× 97 0.3× 276 1.3× 147 5.5k
Toshihiro Takizawa Japan 35 2.2k 1.1× 331 0.8× 376 0.9× 74 0.2× 271 1.3× 142 3.9k
Margaret Fox United Kingdom 30 3.3k 1.7× 817 1.9× 216 0.5× 98 0.3× 147 0.7× 99 4.5k
Antony P. Jackson United Kingdom 34 2.2k 1.1× 225 0.5× 925 2.3× 122 0.3× 116 0.6× 102 3.5k
Park S. Gerald United States 34 1.8k 0.9× 1.2k 2.7× 321 0.8× 473 1.3× 162 0.8× 111 3.6k
Anne Slavotinek United States 38 2.4k 1.2× 2.4k 5.6× 336 0.8× 84 0.2× 1.0k 4.8× 205 4.8k
Michele D’Urso Italy 35 2.8k 1.4× 1.4k 3.3× 469 1.1× 130 0.4× 283 1.4× 100 4.2k
Laurie Jackson‐Grusby United States 27 5.0k 2.6× 1.5k 3.4× 172 0.4× 145 0.4× 311 1.5× 37 5.8k

Countries citing papers authored by Neil Vargesson

Since Specialization
Citations

This map shows the geographic impact of Neil Vargesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Vargesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Vargesson more than expected).

Fields of papers citing papers by Neil Vargesson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Vargesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Vargesson. The network helps show where Neil Vargesson may publish in the future.

Co-authorship network of co-authors of Neil Vargesson

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Vargesson. A scholar is included among the top collaborators of Neil Vargesson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Vargesson. Neil Vargesson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Weiming, David Tweedie, Cindy H. Chau, et al.. (2025). Monoterpenoid fluorophthalimide IMiDs that lack human cereblon binding: synthesis and anti-proliferative, anti-angiogenic and anti-inflammatory activities. Biochemical and Biophysical Research Communications. 779. 152428–152428.
2.
Murcia‐Belmonte, Verónica, Shokoofeh Shamsi, Sophie Shaw, et al.. (2025). Identification of lens-regulated genes driving anterior eye development. Developmental Biology. 520. 91–107. 1 indexed citations
4.
Glotfelty, Elliot J., Shih‐Chang Hsueh, David Tweedie, et al.. (2023). A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders. Biomolecules. 13(5). 747–747. 13 indexed citations
5.
Peach, Megan L., Shaunna Beedie, Cindy H. Chau, et al.. (2020). Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs. Molecules. 25(23). 5683–5683. 14 indexed citations
6.
Vargesson, Neil. (2019). Positional Information—A concept underpinning our understanding of developmental biology. Developmental Dynamics. 249(3). 298–312. 10 indexed citations
7.
Fraga, Lucas Rosa, et al.. (2018). The Primodos components Norethisterone acetate and Ethinyl estradiol induce developmental abnormalities in zebrafish embryos. Scientific Reports. 8(1). 2917–2917. 9 indexed citations
8.
Hootnick, David R. & Neil Vargesson. (2018). The syndrome of proximal femur, fibula, and midline metatarsal long bone deficiencies. Birth Defects Research. 110(15). 1188–1193. 11 indexed citations
9.
Collinson, J. Martin, Nils O. Lindström, Karen Wallace, et al.. (2018). The developmental and genetic basis of ‘clubfoot’ in the peroneal muscular atrophy mutant mouse. Development. 145(3). 13 indexed citations
10.
Luo, Weiming, David Tweedie, Shaunna Beedie, et al.. (2018). Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-α and angiogenesis inhibitory activities. Bioorganic & Medicinal Chemistry. 26(8). 1547–1559. 16 indexed citations
11.
Hettmer, Simone, et al.. (2018). Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma. Scientific Reports. 8(1). 15674–15674. 9 indexed citations
12.
Kuffová, Lucia, et al.. (2018). Limbal epithelial stem cell activity and corneal epithelial cell cycle parameters in adult and aging mice. Stem Cell Research. 33. 185–198. 37 indexed citations
13.
Thompson, Hannah, et al.. (2018). Lens-regulated retinoic acid signalling controls expansion of the developing eye. Development. 145(19). 19 indexed citations
14.
Fraga, Lucas Rosa, et al.. (2017). CPS49‐induced neurotoxicity does not cause limb patterning anomalies in developing chicken embryos. Journal of Anatomy. 232(4). 568–574. 6 indexed citations
15.
Erskine, Lynda, et al.. (2017). VEGF-A and neuropilin 1 (NRP1) shape axon projections in the developing CNS via dual roles in neurons and blood vessels. Development. 144(13). 2504–2516. 41 indexed citations
16.
Vargesson, Neil. (2013). Thalidomide Embryopathy: An Enigmatic Challenge. Aberdeen University Research Archive (Aberdeen University). 2013. 1–18. 41 indexed citations
17.
Erskine, Lynda, et al.. (2009). Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proceedings of the National Academy of Sciences. 106(21). 8573–8578. 181 indexed citations
18.
Vargesson, Neil, et al.. (2001). Characterisation of Hoxa gene expression in the chick limb bud in response to FGF. Developmental Dynamics. 220(1). 87–90. 2 indexed citations
19.
Vargesson, Neil, et al.. (2001). Characterisation ofHoxa gene expression in the chick limb bud in response to FGF. Developmental Dynamics. 220(1). 87–90. 31 indexed citations
20.
Vargesson, Neil, et al.. (1997). Local origin of cells in FGF-4 - induced outgrowth of amputated chick wing bud stumps. The International Journal of Developmental Biology. 41(5). 747–750. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026